Skip to content

A Study of Shirishadi Gel in Treatment of Stretch marks (Kikwisa)

A Single Arm Clinical Study To Evaluate THE Efficacy Of Shirishadi Gel In Management of Kikwisa (Striae Gravidarum)

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/038025
Enrollment
55
Registered
2021-11-15
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O997- Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium

Interventions

None listed

Sponsors

DR DIKSHA PALIWAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Pregnant women of age 19 years and above. 2)Patients having 2 or more signs and symptoms of Kikwisa i.e. kandu(itching),vidaha(burning sensation), rekhaswaroop twak sankoch(stretch marks), vaivarnyata(discoloration). 3)Period of pregnancy from 6th and 7th month onwards. 4)Primigravida and multigravida without previous occurrence of Kikwisa.

Exclusion criteria

Exclusion criteria: 1) Multigravida with previous incidence of Kikwisa. 2)Any type of skin diseases other than Kikwisa. 3)Presence of any other surgical scars.

Design outcomes

Primary

MeasureTime frame
To study the efficacy of Shirishadi gel in management of kandu (itching), vidaha (burning sensation), rekhaswaroop twak sankoch (stretch marks), vaivarnyata (discoloration) in Kikwisa (Striae gravidarum).Timepoint: Shirishadi gel will be given for 30 days, twice a day for local application. Follow up will be taken on day 15th and 30th. Case study will be of 30 days.

Secondary

MeasureTime frame
To study adverse effect of Shirishadi gel in Kikwisa (Striae gravidarum). To do analytical study of Shirishadi gel.Timepoint: Shirishadi gel will be given for 30 days, twice a day for local application. Follow up will be taken on day 15th and 30th. Case study will be of 30 days.

Countries

India

Contacts

Public ContactDR DIKSHA PALIWAL

DR D.Y.PATIL COLLEGE OF AYURVED AND RESEARCH CENTRE,PIMPRI,PUNE

hridaynath.lad@gmail.com9822964454

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026